Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

The emergence of multidrug-resistant strains of Streptococcus pneumoniae drives the development and evaluation of new antipneumococcal agents, especially for the treatment of bacterial meningitis. The aims of the present study were to assess the antibacterial effectiveness of two new quinolones, gar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rodriguez-Cerrato, Violeta, McCoig, Cindy C., Saavedra, Jesus, Barton, Tess, Michelow, Ian C., Hardy, Robert D., Bowlware, Karen, Iglehart, Janie, Katz, Kathy, McCracken, George H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2003
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC148949/
https://ncbi.nlm.nih.gov/pubmed/12499193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.211-215.2003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak